# Determination of Immune Phenotype in Glioblastoma Patients

> **NCT02751138** · — · COMPLETED · sponsor: **University of Ulm** · enrollment: 100 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02751138
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02751138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02751138, "Determination of Immune Phenotype in Glioblastoma Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02751138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*